• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醋酸脱氧皮质酮和16β-羟基脱氢表雄酮对大鼠血压及血浆肾素活性的影响。

Effect of deoxycorticosterone acetate and 16beta-hydroxy-dehydroepiandrosterone on blood pressure and plasma renin activity of rats.

作者信息

Ayachi S, Hall C E, Holland O B, Gomez-Sanchez C

出版信息

Proc Soc Exp Biol Med. 1976 Jun;152(2):218-20. doi: 10.3181/00379727-152-39364.

DOI:10.3181/00379727-152-39364
PMID:132667
Abstract

Intact female Sprague-Dawley rats were given daily injections of either 3.125 mg of deoxycorticosterone or 5.0 mg of 16beta-hydroxy-dehydroepiandrosterone, calculated from the activities reported for each to be equivalent mineralocorticoid dosages. The former caused hypertension, cardiorenal enlargement, increased urine output and depressed PRA. Treatment with 16beta-OH-DHEA had no such effect, raising questions regarding its classification as a mineralocorticoid.

摘要

给成年雌性斯普拉格-道利大鼠每日注射3.125毫克脱氧皮质酮或5.0毫克16β-羟基脱氢表雄酮,根据报道的每种药物的活性计算,二者具有等效的盐皮质激素剂量。前者导致高血压、心肾增大、尿量增加和血浆肾素活性降低。用16β-羟基脱氢表雄酮治疗则没有这种效果,这引发了关于将其归类为盐皮质激素的质疑。

相似文献

1
Effect of deoxycorticosterone acetate and 16beta-hydroxy-dehydroepiandrosterone on blood pressure and plasma renin activity of rats.醋酸脱氧皮质酮和16β-羟基脱氢表雄酮对大鼠血压及血浆肾素活性的影响。
Proc Soc Exp Biol Med. 1976 Jun;152(2):218-20. doi: 10.3181/00379727-152-39364.
2
Blood pressure changes following chronic administration to rats of 3beta,16beta-dihydroxy-5-androsten-17-one, 3beta,17beta-dihydroxy-5-androsten-16-one and 21-hydroxy-4-pregnene-3,20-dione-21-acetate.
Steroids. 1977 Jan;29(1):17-20. doi: 10.1016/0039-128x(77)90105-2.
3
Evidence for a new mineralocorticoid in patients with low-renin essential hypertension.低肾素性原发性高血压患者体内一种新的盐皮质激素的证据。
Circ Res. 1975 Jun;36(6 Suppl 1):2-9. doi: 10.1161/01.res.36.6.2.
4
Mineralocorticoid activity of 16beta-hydroxydehydroepiandrosterone and related steroids.
J Lab Clin Med. 1976 Oct;88(4):571-7.
5
Experimental hypertension and other responses to 18-hydroxy-deoxycorticosterone treatment in the rat.大鼠实验性高血压及对18-羟基脱氧皮质酮治疗的其他反应
Endocrinology. 1978 Jul;103(1):133-40. doi: 10.1210/endo-103-1-133.
6
New mineralocorticoids and adrenocorticosteroids in hypertension.高血压中的新型盐皮质激素和肾上腺皮质类固醇。
Am J Cardiol. 1976 Nov 23;38(6):805-13. doi: 10.1016/0002-9149(76)90359-3.
7
On the mineralocorticoid and hypertensogenic properties of 16beta-hydroxy-dehydroepiandrosterone.关于16β-羟基脱氢表雄酮的盐皮质激素和致高血压特性
Experientia. 1976 Aug 15;32(8):1067-9. doi: 10.1007/BF01933976.
8
Interaction of 16beta-hydroxydehydroepiandrosterone with renal mineralocorticoid receptors.16β-羟基脱氢表雄酮与肾脏盐皮质激素受体的相互作用。
J Lab Clin Med. 1977 Feb;89(2):250-6.
9
[Mineralocorticoid activity and effect on blood pressure of synthetic 16beta-OH-dehydroepiandrosterone and 16-oxoandrostenediol in rats (author's transl)].[合成的16β-羟基脱氢表雄酮和16-氧代雄烯二醇在大鼠体内的盐皮质激素活性及对血压的影响(作者译)]
Nihon Naibunpi Gakkai Zasshi. 1977 Mar 20;53(3):175-82. doi: 10.1507/endocrine1927.53.3_175.
10
Influence of 19-nor-deoxycorticosterone on blood pressure, saline consumption, and serum electrolytes, corticosterone, and renin activity.19-去甲-脱氧皮质酮对血压、盐水摄入量、血清电解质、皮质酮及肾素活性的影响。
Endocrinology. 1979 Sep;105(3):600-4. doi: 10.1210/endo-105-3-600.